Logo

MicroTransponder Receives the US FDA's Approval for Vivistim System as the First Vagus Nerve Stimulation Implant for Stroke Rehabilitation

Share this

MicroTransponder Receives the US FDA's Approval for Vivistim System as the First Vagus Nerve Stimulation Implant for Stroke Rehabilitation

Shots:

  • The approval is based on a study of 108 patients in the US and the UK- that showed patients treated with the Vivistim system had improved mobility than patients in the control group
  • The device used in conjunction with rehabilitation therapy to improve motor function in the hands & arms following ischemic stroke. The system uses an implanted pulse generator to electrically stimulate the vagus nerve- which connects the brain & abdomen and can be used in clinical settings and at home
  • The Vivistim system is a first-of-its-kind- drug-free rehabilitation system to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation

| Ref: FDA | Image: FDA

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions